This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: Omega-3

Omega-3 fatty acids in cardiovascular disease: re-assessing the evidence

May 2012 Br J Cardiol 2012;19:79–84 doi:10.5837/bjc.2012.016

Omega-3 fatty acids in cardiovascular disease: re-assessing the evidence

Alan Begg, Susan Connolly, Julian Halcox, Agnes Kaba, Linda Main, Kausik Ray, Henry Purcell, Helen Williams, Derek Yellon

Abstract

Background Observations on fish consumption in general Populations who consume large amounts of oily fish in their diet tend to have lower rates of coronary heart disease (CHD) and sudden cardiac death (SCD). Fish oils are rich in omega-3 polyunsaturated fatty acids (PUFAs), which have demonstrable cardioprotective properties. In line with these observations, extensive epidemiological data – including large meta-analyses – demonstrate clear associations between both increased fish consumption and increased omega-3 PUFA levels with a favourable cardiovascular prognosis.1-3 Most of the evidence for benefits has been observed in individuals

| Full text

August 2011 Br J Cardiol 2011;18:178

Lifestyle advice and drug therapy post-myocardial infarction: a survey of UK current practice

Julian Halcox, Steven Lindsay, Alan Begg, Kathryn Griffith, Alison Mead, Beverly Barr 

Abstract

Introduction Myocardial infarction (MI) is a common condition, estimated to affect almost 150,000 people per year in the UK.1 Without effective treatment, the immediate mortality of MI approaches 40% with a further 10% of patients dying in the subsequent year.2 In those who survive the initial post-MI period, an increased risk of death from cardiovascular causes (5% per year) persists indefinitely.2 However, effective secondary prevention measures can significantly reduce this risk.3 An estimated 1.4 million people in the UK have had an MI.4 Reducing morbidity and mortality among this group requires effective secondary prevention measures. In

| Full text
News from the American Heart Association Scientific Sessions 2009

February 2010 Br J Cardiol 2010;17:13-18

News from the American Heart Association Scientific Sessions 2009

BJCardio editorial staff

Abstract

ARBITER 6: niacin superior to ezetimibe for slowing atherosclerosis Use of extended-release niacin resulted in a significant benefit on atherosclerosis compared with ezetimibe in patients already taking statins in the ARBITER 6-HALTS trial. The trial, presented at the meeting by Dr Allen Taylor (Medstar Research Institute, Washington DC, US), compared two distinct lipid-modifying strategies in patients with known vascular disease already on statins who had LDL-cholesterol levels <100 mg/dL (2.56 mmol/L) and moderately low HDL-cholesterol levels (<50 mg/dL [1.28 mmol/L]). Among the 363 patients enrolled in the study, half were randomised

| Full text

January 2004 Br J Cardiol 2004;11:16-21

Omega-3 polyunsaturated fatty acids: mechanisms and clinical applications explored

BJCardio editorial team

Abstract

No content available

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now